enGene Therapeutics Inc 10-K for FY2024
enGene Therapeutics Inc. (ENGN)
10-K
2024-12-19
For: 2024-10-31
View Original
Added on
April 10, 2026
About this 10-K
enGene Therapeutics Inc filed this 10-K on December 19, 2024, covering the fiscal year ended October 31, 2024 (FY2024).
Headline figures
Fiscal year ended October 31, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Net loss
- $55.14M
- compared with a net loss of $99.92M a year earlier
- Diluted EPS
- $1.46
- down 99.0% from $151.22 a year earlier